SB 1504
Allows for the provision of epinephrine in schools by methods other than injections.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take actionPublic sentiment
Support
100%
Oppose
0%
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Bill overview
This bill allows schools to use epinephrine for students with asthma or severe allergies using methods other than traditional injections, such as autoinjectors or intranasal devices. It expands training requirements for school staff on administering these medications and ensures backup epinephrine is available. The bill also clarifies liability protections for schools and staff when assisting students with these conditions.
Sponsors
Official sponsors from legislative records.
Primary sponsors
Cosponsors
Arguments in favor
Reasons to support this legislation.
Supporters of Senate Bill 1504 and proposed updates to Oregon law agree that modernizing school health policy will improve outcomes for students with severe allergies. They argue that allowing premeasured doses of epinephrine to be administered in forms other than injections, such as intranasal devices, can lead to faster treatment and better outcomes. Proponents also emphasize the need for rapid access to life-saving treatment in case of anaphylaxis, citing the importance of stocking FDA-approved emergency systems in schools. By updating Oregon law to reflect these changes, supporters believe that students will be better protected and more likely to receive timely medical attention when needed.
Source: Testimony Summaries
Arguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.